United States · Series C startup

Who invested in Pervasis Therapeutics

4 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 27 Oct 2026

$45Mraised across 4 rounds since 2004, from 4 sources

$500KSeed$17MSeries B$9.8MVenture$17MSeries C
Latest round
Series C, $17MAug 2009
Biggest round
$17MSeries B · Aug 2005
Step-upi
1.8×
Investors
5
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

200420052006200720082009
$500KSeed$17MSeries B$9.8MVenture$17MSeries C
First round
Seed, $500K
Mar 2004
Biggest round
$17M
Series B · Aug 2005
Usual gap between rounds
20 months
the median of 3

The rounds

  1. Aug 2009
    Series C$17M3 returning

    Reported by news.prnewswire.comSEC filing: $10M sold, first sale Aug 2009

  2. Jan 2008
  3. Aug 2005
    Series B$17M2 new1 returning

    From a historical funding record

  4. Mar 2004
    Seed$500K2 new

    From a historical funding record

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

Polaris PartnersVC firm4rounds
Flagship VenturesAccelerator1round
Musket Research AssociatesInvestment firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Pervasis Therapeutics

Who invested in Pervasis Therapeutics?

Pervasis Therapeutics's investors include Polaris Partners, Highland Capital Partners, Flagship Pioneering, LLC, Flagship Ventures and Musket Research Associates.

How much has Pervasis Therapeutics raised?

Pervasis Therapeutics has raised $45M across 4 rounds since 2004.

When did Pervasis Therapeutics last raise?

Pervasis Therapeutics's most recent round was a Series C of $17M in Aug 2009.

What was Pervasis Therapeutics's biggest round?

Pervasis Therapeutics's largest round on record is $17M (Series B), in Aug 2005.

Who backed Pervasis Therapeutics first?

Pervasis Therapeutics's first round on record, in Mar 2004, was backed by Polaris Partners and Flagship Ventures.

What stage is Pervasis Therapeutics at?

Pervasis Therapeutics's latest named round is a Series C, in Aug 2009.

Where is Pervasis Therapeutics based?

Pervasis Therapeutics is based in the United States.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.